A Fucose-containing Hetero-exopolysaccharide From Levilactobacillus brevis B151 Exhibits Potent Antimicrobial, Antibiofilm, and Antioxidant Activities
- 12 November 2025
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 18 (4) , 5509-5524
Abstract
Exopolysaccharides (EPSs) have recently emerged as significant substances due to their remarkable biological properties. This research aimed to analyze EPS B151 extracted from Levilactobacillus brevis B151 and evaluate its biological activities. EPS B151 was obtained at a yield of 438 mg/L. Structural analysis using the Congo red method and Fourier transform infrared spectroscopy (FTIR) revealed a random coil structure and characteristic typical carbohydrate peaks (O-H, C-H, C = O, and C-O-C), along with a pyranose ring containing both α- and β-glycosidic bonds. Scanning electron microscopy (SEM) revealed a porous, irregular, and loosely compact morphology. High-pressure liquid chromatography (HPLC) analysis indicated that EPS B151 is a heteropolysaccharide composed of mannose, ribose, glucosamine, glucuronic acid, glucose, galactose, and the rare sugar fucose. This unique composition is the first reported for an L. brevis-derived EPS. EPS B151 demonstrated significant antimicrobial activity against Staphylococcus aureus KFRI00188 and Listeria monocytogenes ATCC3596, inhibiting growth and cell viability in a dose-dependent manner, with bactericidal effects confirmed by propidium iodide staining and SEM analysis. It also inhibited biofilm formation (up to 58.09 ± 2.97% for Staph. aureus and 51.53 ± 3.84% for L. monocytogenes) in a dose-dependent manner. Furthermore, EPS B151 demonstrated potent antioxidant activity in multiple in vitro assays, including ABTS•+, DPPH, and OH• radical-scavenging, along with significant reducing power. In cytotoxicity assays, EPS B151 was non-toxic to normal colon cells (CCD-18Co) but showed significant inhibitory effects against colon cancer (Caco-2) and gastric cancer (AGS) cell lines, suggesting its potential anticancer properties. Overall, EPS B151 is a multifunctional bioactive compound with antimicrobial, antibiofilm, antioxidant, and anticancer properties, highlighting its potential as a functional ingredient in the food, biomedical, and pharmaceutical industries.Keywords
Funding Information
- National Research Foundation of Korea (NRF-RS-2023-00275307)
- Ministry of Agriculture, Food and Rural Affairs (321035052HD040)
This publication has 53 references indexed in Scilit:
- Exploring the purification, characterization, and industrial applications of Exopolysaccharide (EPS) from Bacillus amyloliquefaciens strain BDIFST240014Molecular Biology Reports, 2024
- Preparation of Novel Marine Enterococcus faecium MSD8 Exopolysaccharide Ointment and In Vivo Evaluation of Its Impact on Cutaneous Wound Healing in Male Albino RatsProbiotics and Antimicrobial Proteins, 2024
- Production, Purification, and Characterization of a Novel Exopolysaccharide from Probiotic Lactobacillus amylovorus: MTCC 8129Indian Journal of Microbiology, 2024
- Weissellicin LM85 Purified from Weissella confusa LM85 Effluxes Potassium Ions and Depletes Proton Motive Force in Escherichia coli ATCC 25922International Journal of Peptide Research and Therapeutics, 2024
- Hetero-exopolysaccharide from the extremely halophilic Halomonas smyrnensis K2: production, characterization and functional properties in vitro3 Biotech, 2020
- Antibacterial and antioxidant activity of exopolysaccharide mediated silver nanoparticle synthesized by Lactobacillus brevis isolated from Chinese koumissColloids and Surfaces B: Biointerfaces, 2020
- Tracking of deliberately inoculated Leuconostoc mesenteroides and Lactobacillus brevis in kimchiFood Science and Biotechnology, 2019
- A comprehensive review of anticancer, immunomodulatory and health beneficial effects of the lactic acid bacteria exopolysaccharidesCarbohydrate Polymers, 2019
- Multidrug resistant pathogenic bacterial biofilm inhibition by Lactobacillus plantarum exopolysaccharideBioactive Carbohydrates and Dietary Fibre, 2016
- Fucose-containing exopolysaccharide produced by the newly isolated Enterobacter strain A47 DSM 23139Carbohydrate Polymers, 2011